Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34


Trends in the Prevalence of Intraoperative Adverse Events at 2 Academic Hospitals After Implementation of a Mandatory Reporting System.

Wanderer JP, Gratch DM, Jacques PS, Rodriquez LI, Epstein RH.

Anesth Analg. 2017 Aug 30. doi: 10.1213/ANE.0000000000002447. [Epub ahead of print]


A comparison of two psychological interventions for newly-diagnosed gynecological cancer patients.

Manne SL, Virtue SM, Ozga M, Kashy D, Heckman C, Kissane D, Rosenblum N, Morgan M, Rodriquez L.

Gynecol Oncol. 2017 Feb;144(2):354-362. doi: 10.1016/j.ygyno.2016.11.025. Epub 2016 Nov 23.


Default Drug Doses in Anesthesia Information Management Systems.

Rodriquez LI, Smaka TJ, Mahla M, Epstein RH.

Anesth Analg. 2017 Jul;125(1):255-260. doi: 10.1213/ANE.0000000000001611.


Live tissue versus simulation training for emergency procedures: Is simulation ready to replace live tissue?

Barnes SL, Bukoski A, Kerby JD, Llerena L, Armstrong JH, Strayhorn C; University of Missouri Combat Casualty Training Consortium.

Surgery. 2016 Oct;160(4):997-1007. doi: 10.1016/j.surg.2016.04.044. Epub 2016 Aug 6.


National Association of Clinical Nurse Specialists news: President's message.

Rodriquez L.

Clin Nurse Spec. 2015 Mar-Apr;29(2):61-2. doi: 10.1097/01.NUR.0000460513.70744.2f. No abstract available.


National Association of Clinical Nurse Specialists news: Presidents message, June 2014.

Rodriquez L.

Clin Nurse Spec. 2014 Sep-Oct;28(5):251-2. doi: 10.1097/01.NUR.0000452359.19046.9d. No abstract available.


Venue-based recruitment of women at elevated risk for HIV: an HIV Prevention Trials Network study.

Haley DF, Golin C, El-Sadr W, Hughes JP, Wang J, Roman Isler M, Mannheimer S, Kuo I, Lucas J, DiNenno E, Justman J, Frew PM, Emel L, Rompalo A, Polk S, Adimora AA, Rodriquez L, Soto-Torres L, Hodder S.

J Womens Health (Larchmt). 2014 Jun;23(6):541-51. doi: 10.1089/jwh.2013.4654. Epub 2014 Apr 17.


Percutaneous repair or surgery for mitral regurgitation.

Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L; EVEREST II Investigators.

N Engl J Med. 2011 Apr 14;364(15):1395-406. doi: 10.1056/NEJMoa1009355. Epub 2011 Apr 4. Erratum in: N Engl J Med. 2011 Jul 14;365(2):189. Glower, Donald G [corrected to Glower, Donald D].


Medication adherence in children and adolescents with HIV infection: associations with behavioral impairment.

Malee K, Williams P, Montepiedra G, McCabe M, Nichols S, Sirois PA, Storm D, Farley J, Kammerer B; PACTG 219C Team.

AIDS Patient Care STDS. 2011 Mar;25(3):191-200. doi: 10.1089/apc.2010.0181. Epub 2011 Feb 16.


Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM; PACTG 219C Team.

Pediatrics. 2010 Feb;125(2):e250-60. doi: 10.1542/peds.2009-1112. Epub 2010 Jan 18.


The use of second-generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV.

Kapetanovic S, Aaron L, Montepiedra G, Sirois PA, Oleske JM, Malee K, Pearson DA, Nichols SL, Garvie PA, Farley J, Nozyce ML, Mintz M, Williams PL; Pediatric AIDS Clinical Trials.

AIDS Patient Care STDS. 2009 Nov;23(11):939-47. doi: 10.1089/apc.2009.0121.


Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV.

Sirois PA, Montepiedra G, Kapetanovic S, Williams PL, Pearson DA, Malee K, Garvie PA, Kammerer BL, Nichols SL, Nozyce ML, Mintz M, Mitchell WG, Oleske JM; IMPAACT/PACTG 219C Team.

J Dev Behav Pediatr. 2009 Oct;30(5):403-12.


Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents.

Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd; International Maternal Pediatric Adolescent AIDS Clinical Trials 219/219C Study Team.

AIDS. 2009 Sep 10;23(14):1893-901. doi: 10.1097/QAD.0b013e32832dc041.


The role of cognitive functioning in medication adherence of children and adolescents with HIV infection.

Malee K, Williams PL, Montepiedra G, Nichols S, Sirois PA, Storm D, Farley J, Kammerer B; PACTG 219C Team.

J Pediatr Psychol. 2009 Mar;34(2):164-75. doi: 10.1093/jpepsy/jsn068. Epub 2008 Jul 22.


Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting.

Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Dyke RB, Seage GR 3rd; Pediatric AIDS Clinical Trials Group 219/219C Study Team.

Clin Infect Dis. 2008 Jun 1;46(11):1751-60. doi: 10.1086/587900.


Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.

Tassiopoulos K, Williams PL, Seage GR 3rd, Crain M, Oleske J, Farley J; International Maternal Pediatric Adolescent AIDS Clinical Trials 219C Team.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):607-14. doi: 10.1097/QAI.0b013e3181648e16.


Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188 Re in adult recurrent high-grade glioma.

Casacó A, López G, García I, Rodríguez JA, Fernández R, Figueredo J, Torres L, Perera A, Batista J, Leyva R, Peña Y, Amador Z, González A, Estupiñan B, Coca M, Hernández A, Puig M, Iglesias M, Hernández A, Ramos M, Rodríquez L, Suarez N.

Cancer Biol Ther. 2008 Mar;7(3):333-9. Epub 2007 Dec 13.


Systemic and skin toxicity in Cercopithecus aethiops sabaeus monkeys treated during 26 weeks with a high intravenous dose of the anti- epidermal growth factor receptor monoclonal antibody Nimotuzumab.

Arteaga ME, Ledón N, Casacó A, Pardo B, García M, Boleda M, Viña L, Orphee R, Hernández O, González C, Fuentes D, Rodríguez V, Charro L, Baro F, Macías A, Pérez A, Morales Y, Subirós N, González B, Ramos M, Rodriquez L, Ballester-Labrada A, Crombet T.

Cancer Biol Ther. 2007 Sep;6(9):1390-5. Epub 2007 Jun 5.


Early activity is feasible and safe in respiratory failure patients.

Bailey P, Thomsen GE, Spuhler VJ, Blair R, Jewkes J, Bezdjian L, Veale K, Rodriquez L, Hopkins RO.

Crit Care Med. 2007 Jan;35(1):139-45.


Supplemental Content

Loading ...
Support Center